Cargando…
Weight Loss Improves Pregnancy and Livebirth Outcomes in Young Women with Early-Stage Endometrial Cancer and Atypical Hyperplasia
PURPOSE: To evaluate the effects of body weight loss on reproductive outcomes in young women with early-stage endometrial cancer (EC) and atypical hyperplasia (AH) who underwent fertility-sparing therapy. PATIENTS AND METHODS: Patients with well-differentiated EC (n=8, FIGO stage Ia) and AH (n=36) w...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286730/ https://www.ncbi.nlm.nih.gov/pubmed/34285588 http://dx.doi.org/10.2147/CMAR.S316040 |
_version_ | 1783723774224367616 |
---|---|
author | Zhang, Yanfang Li, Dan Yan, Qi Song, Xueru Tian, Wenyan Wang, Yingmei Teng, Fei Wei, Likun Wang, Jinghua Zhang, Huiying Xue, Fengxia |
author_facet | Zhang, Yanfang Li, Dan Yan, Qi Song, Xueru Tian, Wenyan Wang, Yingmei Teng, Fei Wei, Likun Wang, Jinghua Zhang, Huiying Xue, Fengxia |
author_sort | Zhang, Yanfang |
collection | PubMed |
description | PURPOSE: To evaluate the effects of body weight loss on reproductive outcomes in young women with early-stage endometrial cancer (EC) and atypical hyperplasia (AH) who underwent fertility-sparing therapy. PATIENTS AND METHODS: Patients with well-differentiated EC (n=8, FIGO stage Ia) and AH (n=36) who achieved complete regression after fertility-sparing therapy were retrospectively reviewed. Patients were divided into a weight loss group (n=25) and a non-weight loss group (n=19). Subgroup analysis according to body mass index and relative weight loss were performed to investigate the effect of weight loss on pregnancy and live birth outcomes. Univariate and multivariate logistic regression analyses were undertaken to determine pregnancy-associated factors. RESULTS: Mean body weight and body mass index at pre-progestin treatment and at fertility treatment initiation were 70.63±12.03 and 67.08±8.18 kg, respectively, 27.06±4.44 and 25.73±3.15 kg/m(2), respectively. Twenty-five patients (56.82%) lost weight, the median absolute weight loss was 5.00 kg (1.00–34.50), and the median relative weight loss was 6.70% (1.00–36.00%) over a median of 12 months (5.00–97.00). A favorable pregnancy rate (65.91%) and live birth rate (50.00%) were achieved. The pregnancy and live birth rates were meaningfully higher in the weight loss group than in the non-weight loss group (88.00% vs 36.84%, P=0.000; 64.00% vs 31.58%, P=0.033); weight loss ≥5% significantly increased pregnancy and live birth rate in patients with BMI ≥25 kg/m(2). The risk ratio of weight loss ≥5% in multivariate logistic analysis for pregnancy was 10.448 (1.102, 99.056, P=0.041). CONCLUSION: Weight loss could positively affect pregnancy rate and improve live birth rate in overweight and obese women with early-stage EC and AH during/after fertility-sparing therapy. Weight loss ≥5% increased pregnancy and livebirth rates significantly in overweight and obese women. |
format | Online Article Text |
id | pubmed-8286730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-82867302021-07-19 Weight Loss Improves Pregnancy and Livebirth Outcomes in Young Women with Early-Stage Endometrial Cancer and Atypical Hyperplasia Zhang, Yanfang Li, Dan Yan, Qi Song, Xueru Tian, Wenyan Wang, Yingmei Teng, Fei Wei, Likun Wang, Jinghua Zhang, Huiying Xue, Fengxia Cancer Manag Res Original Research PURPOSE: To evaluate the effects of body weight loss on reproductive outcomes in young women with early-stage endometrial cancer (EC) and atypical hyperplasia (AH) who underwent fertility-sparing therapy. PATIENTS AND METHODS: Patients with well-differentiated EC (n=8, FIGO stage Ia) and AH (n=36) who achieved complete regression after fertility-sparing therapy were retrospectively reviewed. Patients were divided into a weight loss group (n=25) and a non-weight loss group (n=19). Subgroup analysis according to body mass index and relative weight loss were performed to investigate the effect of weight loss on pregnancy and live birth outcomes. Univariate and multivariate logistic regression analyses were undertaken to determine pregnancy-associated factors. RESULTS: Mean body weight and body mass index at pre-progestin treatment and at fertility treatment initiation were 70.63±12.03 and 67.08±8.18 kg, respectively, 27.06±4.44 and 25.73±3.15 kg/m(2), respectively. Twenty-five patients (56.82%) lost weight, the median absolute weight loss was 5.00 kg (1.00–34.50), and the median relative weight loss was 6.70% (1.00–36.00%) over a median of 12 months (5.00–97.00). A favorable pregnancy rate (65.91%) and live birth rate (50.00%) were achieved. The pregnancy and live birth rates were meaningfully higher in the weight loss group than in the non-weight loss group (88.00% vs 36.84%, P=0.000; 64.00% vs 31.58%, P=0.033); weight loss ≥5% significantly increased pregnancy and live birth rate in patients with BMI ≥25 kg/m(2). The risk ratio of weight loss ≥5% in multivariate logistic analysis for pregnancy was 10.448 (1.102, 99.056, P=0.041). CONCLUSION: Weight loss could positively affect pregnancy rate and improve live birth rate in overweight and obese women with early-stage EC and AH during/after fertility-sparing therapy. Weight loss ≥5% increased pregnancy and livebirth rates significantly in overweight and obese women. Dove 2021-07-14 /pmc/articles/PMC8286730/ /pubmed/34285588 http://dx.doi.org/10.2147/CMAR.S316040 Text en © 2021 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zhang, Yanfang Li, Dan Yan, Qi Song, Xueru Tian, Wenyan Wang, Yingmei Teng, Fei Wei, Likun Wang, Jinghua Zhang, Huiying Xue, Fengxia Weight Loss Improves Pregnancy and Livebirth Outcomes in Young Women with Early-Stage Endometrial Cancer and Atypical Hyperplasia |
title | Weight Loss Improves Pregnancy and Livebirth Outcomes in Young Women with Early-Stage Endometrial Cancer and Atypical Hyperplasia |
title_full | Weight Loss Improves Pregnancy and Livebirth Outcomes in Young Women with Early-Stage Endometrial Cancer and Atypical Hyperplasia |
title_fullStr | Weight Loss Improves Pregnancy and Livebirth Outcomes in Young Women with Early-Stage Endometrial Cancer and Atypical Hyperplasia |
title_full_unstemmed | Weight Loss Improves Pregnancy and Livebirth Outcomes in Young Women with Early-Stage Endometrial Cancer and Atypical Hyperplasia |
title_short | Weight Loss Improves Pregnancy and Livebirth Outcomes in Young Women with Early-Stage Endometrial Cancer and Atypical Hyperplasia |
title_sort | weight loss improves pregnancy and livebirth outcomes in young women with early-stage endometrial cancer and atypical hyperplasia |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286730/ https://www.ncbi.nlm.nih.gov/pubmed/34285588 http://dx.doi.org/10.2147/CMAR.S316040 |
work_keys_str_mv | AT zhangyanfang weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia AT lidan weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia AT yanqi weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia AT songxueru weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia AT tianwenyan weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia AT wangyingmei weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia AT tengfei weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia AT weilikun weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia AT wangjinghua weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia AT zhanghuiying weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia AT xuefengxia weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia |